Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Gilead agreed to buy private German biotech Tubulis in a deal worth up to $5 billion as it looks to boost its portfolio in a hot new area of cancer drug development. (Source: Bloomberg)
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Gilead agreed to buy private German biotech Tubulis in a deal worth up to $5 billion as it looks to boost its portfolio in a hot new area of cancer drug development. (Source: Bloomberg)
Tyson Fury says he is "as sharp as I've ever been" ahead of his fight against Arslanbek Makhmudov at the Tottenham Hotspur Stadium and is keen to take on fellow British heavyweight Anthony Joshua, after Saturday's bout.
Tyson Fury says he is "as sharp as I've ever been" ahead of his fight against Arslanbek Makhmudov at the Tottenham Hotspur Stadium and is keen to take on fellow British heavyweight Anthony Joshua, after Saturday's bout.
Shares of Meta Platforms rose 6% after the company announced its first major new artificial-intelligence model in more than a year. The new model, called Muse Spark, will power Meta’s AI chatbot and AI features within it.
Shares of Meta Platforms rose 6% after the company announced its first major new artificial-intelligence model in more than a year. The new model, called Muse Spark, will power Meta’s AI chatbot and AI features within it.
Richard Drury/DigitalVision via Getty Images Investment Overview: Vor's Transformative 2025 - Pivot To Immunology & >$500m Fundraisings When I last covered Vor Biopharma Inc. ( VOR ) back in December last year , analysts at JPMorgan Chase ( JPM ) had just initiated coverage on the company with an Overweight recommendation and a price target of $43, based on "blockbuster" (>$1bn per annum) estimate...
Richard Drury/DigitalVision via Getty Images Investment Overview: Vor's Transformative 2025 - Pivot To Immunology & >$500m Fundraisings When I last covered Vor Biopharma Inc. ( VOR ) back in December last year , analysts at JPMorgan Chase ( JPM ) had just initiated coverage on the company with an Overweight recommendation and a price target of $43, based on "blockbuster" (>$1bn per annum) estimates for peak annual telitacicept revenues. At the time, Vor stock traded at $10.2 per share, and I was more circumspect, assigning the stock a Hold rating. Today, the stock trades at $16.6 per share, up nearly 60%. In June last year, Vor, a failing cell therapy drug developer that looked as if it were heading for delisting/insolvency, struck a deal with China-based Pharma RemeGen to acquire the rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis - as per the terms of the deal: RemeGen receives initial payment of $125 million consisting of an upfront payment of $45 million plus $80 million of warrants, potential regulatory and commercial milestones exceeding $4 billion, as well as tiered royalties. Vor raised a significant amount of funding in 2025 also, according to its 2025 annual report/ 10-K filing : Net cash provided by financing activities was $503.8 million for the year ended December 31, 2025, which consisted of $175.0 million of proceeds from the June 2025 Private Placement, $150.0 million of proceeds from the December 2025 Private Placement, $108.1 million of proceeds received from the November 2025 Offering, $70.1 million of proceeds from the sale of common stock under the Stifel ATM Facility, and proceeds of $2.2 million from the exercise of stock options and purchases of common stock under our ESPP. The company has also issued substantial amounts of unexercised warrants (the right, but not obligation, to buy shares in the company in the future at a prespec...
Bloomberg's Laura Benitez joins Dani Burger on "Bloomberg Deals." Pacific Investment Management is in talks with Bank of America to help provide roughly $14 billion of debt financing to build a massive Oracle Corp. data center in Michigan, according to people familiar with the matter. (Source: Bloomberg)
Bloomberg's Laura Benitez joins Dani Burger on "Bloomberg Deals." Pacific Investment Management is in talks with Bank of America to help provide roughly $14 billion of debt financing to build a massive Oracle Corp. data center in Michigan, according to people familiar with the matter. (Source: Bloomberg)
J2R/iStock Editorial via Getty Images One of the market's biggest winners in recent weeks has been VinFast Auto Ltd. ( VFS ). The Vietnamese electric vehicle and scooter maker has seen its shares surge more than 30% after reporting its fourth-quarter results . While the company is showing large revenue growth that's expected to continue this year, it is also racking up significant losses and cash ...
J2R/iStock Editorial via Getty Images One of the market's biggest winners in recent weeks has been VinFast Auto Ltd. ( VFS ). The Vietnamese electric vehicle and scooter maker has seen its shares surge more than 30% after reporting its fourth-quarter results . While the company is showing large revenue growth that's expected to continue this year, it is also racking up significant losses and cash burn that make me question the recent rally in shares. Previous Coverage Of VinFast Auto The last time I looked at VinFast was back in November 2025, right after the company had reported its third-quarter results . I liked the sales trajectory, but not the losses and cash burn. The balance sheet wasn't in great shape, but the company was receiving a lot of financial support from related parties. Since that time, shares have rallied more than 21%, compared to a small decline in the S&P 500, but VinFast remains well below where I first went to a sell rating and even further off its all-time highs. VinFast Q4 Results And Recent Updates In the final quarter of 2025, VinFast delivered over 86,550 electric vehicles, up 127% over the prior year period. Electric scooter and bike sales came in at nearly 172,000, up from just 31,000 in the prior year period. This led total revenues to come in at nearly $1.57 billion for Q4. Not only was this number up roughly 139% over Q4 2024, but it handily beat street estimates by around $439 million. In both dollar and percentage terms, this was the largest beat of analyst expectations in the company's public trading history. The problem for VinFast is that it hasn't gotten its cost base under control just yet. The gross loss was over $626 million in Q4, an increase of more than 20% from the prior year period. The company's gross margin percentage did improve substantially from about negative 79% to negative 40%, but that was mainly a function of the revenue surge. The company reported an operating loss of more than $1.15 billion for Q4 2025, a n...
The post Inside the Mind of an Active Trader, and How Direxion Can Help Them Use Leveraged ETFs During Major Market Events by Benzinga Contributors appeared first on Benzinga . Visit Benzinga to get more great content like this. At the end of November 2025, there was about $160.5 billion invested in leveraged exchange-traded funds and notes (ETFs and ETNs). At that point, fund volumes accounted fo...
The post Inside the Mind of an Active Trader, and How Direxion Can Help Them Use Leveraged ETFs During Major Market Events by Benzinga Contributors appeared first on Benzinga . Visit Benzinga to get more great content like this. At the end of November 2025, there was about $160.5 billion invested in leveraged exchange-traded funds and notes (ETFs and ETNs). At that point, fund volumes accounted for approximately 8% of total trading activity on U.S. stock exchanges. Zoom in on those funds and you’ll see that about 90% of turnover comes from active retail traders. These products have served these traders by democratizing access to institutional-like strategies in products that are readily available. Direxion specializes in providing leveraged ETFs for traders to magnify short term perspectives, utilize bull and bear funds for both sides of the trade, and trade through rapidly changing markets. Below, we’ll dive deeper into how active traders utilized leveraged EFTs during recent major market events. Active Traders And Leveraged Funds During the 2020 COVID Bear Market If you had to mark the exact moment in history where the current retail investment boom started, it’d likely be here. There were plenty of market dislocations and swings to capitalize on, and retail traders did so via leverage. Turnover in leveraged ETFs more than quadrupled during the depths of the COVID selloff, and retail traders flipped between bull and bear positions in long and short* funds, moving increasingly into inverse ETFs as stock prices dropped. Those traders turned bullish at the trough of the selloff, a day when the S&P jumped 9.4%, and traders’ appetites for higher prices were cemented after the benchmark crept within 7% of a record high that July. You’d think traders would feel emboldened in their positions as prices moved. Turns out the opposite was true. Active retail traders moved out of 3X leveraged funds into lower-leveraged products as the selloff progressed. Active Traders And Lev...
Alphabet‘s (NASDAQ:GOOGL) stock is up 4% in Wednesday’s session, moving from $305.46 to $317 as investors cheer the latest geographic expansion of Waymo’s autonomous ride-hailing service. That gain outpaced the broader Communication Services sector, which rose 1.47% on the day, signaling that today’s move is driven by stock-specific momentum rather than a broad sector lift. ... Alphabet Climbs 4% ...
Alphabet‘s (NASDAQ:GOOGL) stock is up 4% in Wednesday’s session, moving from $305.46 to $317 as investors cheer the latest geographic expansion of Waymo’s autonomous ride-hailing service. That gain outpaced the broader Communication Services sector, which rose 1.47% on the day, signaling that today’s move is driven by stock-specific momentum rather than a broad sector lift. ... Alphabet Climbs 4% on Waymo’s Nashville Expansion: The Self-Driving Bet Is Starting to Pay Off